skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Hydroxymethyl phosphine compounds for use as diagnostic and therapeutic pharmaceuticals and method of making same

Abstract

A compound and method of making a compound for use as a diagnostic or therapeutic pharmaceutical comprises at least one functionalized hydroxyalkyl phosphine donor group and one or more sulfur or nitrogen donor and a metal combined with the ligand.

Inventors:
; ; ; ; ;
Publication Date:
Research Org.:
US Department of Energy, Washington, DC (US)
Sponsoring Org.:
USDOE
OSTI Identifier:
20023227
Application Number:
Int. Cl. A61K 51/04; C07F 5/00; C07F 9/00; US 6,054,115/A/; 9-033,928; TRN: IM200020%%162
Assignee:
PTO; EDB-00:020620
Resource Type:
Patent
Resource Relation:
Other Information: PBD: 25 Apr 2000
Country of Publication:
United States
Language:
English
Subject:
62 RADIOLOGY AND NUCLEAR MEDICINE; DRUGS; USES; CHEMICAL PREPARATION; PHOSPHINES; ORGANIC PHOSPHORUS COMPOUNDS; LIGANDS

Citation Formats

Katti, K V, Karra, S R, Berning, D E, Smith, C J, Volkert, W A, and Ketring, A R. Hydroxymethyl phosphine compounds for use as diagnostic and therapeutic pharmaceuticals and method of making same. United States: N. p., 2000. Web.
Katti, K V, Karra, S R, Berning, D E, Smith, C J, Volkert, W A, & Ketring, A R. Hydroxymethyl phosphine compounds for use as diagnostic and therapeutic pharmaceuticals and method of making same. United States.
Katti, K V, Karra, S R, Berning, D E, Smith, C J, Volkert, W A, and Ketring, A R. Tue . "Hydroxymethyl phosphine compounds for use as diagnostic and therapeutic pharmaceuticals and method of making same". United States.
@article{osti_20023227,
title = {Hydroxymethyl phosphine compounds for use as diagnostic and therapeutic pharmaceuticals and method of making same},
author = {Katti, K V and Karra, S R and Berning, D E and Smith, C J and Volkert, W A and Ketring, A R},
abstractNote = {A compound and method of making a compound for use as a diagnostic or therapeutic pharmaceutical comprises at least one functionalized hydroxyalkyl phosphine donor group and one or more sulfur or nitrogen donor and a metal combined with the ligand.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {2000},
month = {4}
}